APA (7th ed.) Citation

Amengual, J., Gonzalez-Sanchez, E., Yáñez-Bartolome, M., Sererols-Viñas, L., Ravichandra, A., Guiton, C., . . . Vaquero, J. (2025). NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts. Signal transduction and targeted therapy, 10, . https://doi.org/10.1038/s41392-025-02347-z

Chicago Style (17th ed.) Citation

Amengual, Josep, et al. "NADPH Oxidase 1/4 Dual Inhibition Impairs Transforming Growth Factor-beta Protumorigenic Effects in Cholangiocarcinoma Cancer-associated Fibroblasts." Signal Transduction and Targeted Therapy 10 (2025). https://doi.org/10.1038/s41392-025-02347-z.

MLA (9th ed.) Citation

Amengual, Josep, et al. "NADPH Oxidase 1/4 Dual Inhibition Impairs Transforming Growth Factor-beta Protumorigenic Effects in Cholangiocarcinoma Cancer-associated Fibroblasts." Signal Transduction and Targeted Therapy, vol. 10, 2025, https://doi.org/10.1038/s41392-025-02347-z.